Finally, NFAT5 depletion in myeloid cells significantly reduces inflammation and insulin resistance in mice with high-fat diet-induced obesity 170, underscoring its potential as a target for improving metabolic outcomes in obesity and T2DM. Here, NFAT5 is linked to type 2 diabetes mellitus.